Csenge Advisory Group’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.71M | Sell |
19,723
-3,535
| -15% | -$339K | 0.08% | 213 |
|
|
2025
Q4 | $2.23M | Buy |
23,258
+10,868
| +88% | +$1.06M | 0.1% | 174 |
|
|
2025
Q3 | $1.18M | Buy |
12,390
+6,195
| +100% | +$569K | 0.06% | 260 |
|
|
2025
Q2 | $514K | Sell |
6,195
-1,488
| -19% | -$126K | 0.03% | 423 |
|
|
2025
Q1 | $635K | Sell |
7,683
-5,171
| -40% | -$463K | 0.04% | 341 |
|
|
2024
Q4 | $1.03M | Buy |
12,854
+4,517
| +54% | +$391K | 0.06% | 261 |
|
|
2024
Q3 | $745K | Buy |
8,337
+311
| +4% | +$26.2K | 0.04% | 335 |
|
|
2024
Q2 | $632K | Sell |
8,026
-3,495
| -30% | -$287K | 0.04% | 355 |
|
|
2024
Q1 | $1M | Buy |
11,521
+1,820
| +19% | +$155K | 0.06% | 262 |
|
|
2023
Q4 | $799K | Sell |
9,701
-1,672
| -15% | -$127K | 0.05% | 290 |
|
|
2023
Q3 | $891K | Buy |
11,373
+744
| +7% | +$62.3K | 0.06% | 230 |
|
|
2023
Q2 | $936K | Sell |
10,629
-672
| -6% | -$57.9K | 0.06% | 227 |
|
|
2023
Q1 | $911K | Buy |
11,301
+2,192
| +24% | +$179K | 0.07% | 224 |
|
|
2022
Q4 | $708K | Sell |
9,109
-678
| -7% | -$55K | 0.05% | 268 |
|
|
2022
Q3 | $790K | Sell |
9,787
-372
| -4% | -$33.4K | 0.07% | 241 |
|
|
2022
Q2 | $912K | Buy |
10,159
+1,678
| +20% | +$170K | 0.08% | 227 |
|
|
2022
Q1 | $941K | Buy |
8,481
+599
| +8% | +$63.3K | 0.07% | 231 |
|
|
2021
Q4 | $994K | Sell |
7,882
-861
| -10% | -$99.7K | 0.09% | 196 |
|
|
2021
Q3 | $1.11M | Buy |
8,743
+861
| +11% | +$111K | 0.09% | 195 |
|
|
2021
Q2 | $994K | Sell |
7,882
-1,008
| -11% | -$127K | 0.09% | 196 |
|
|
2021
Q1 | $1.08M | Sell |
8,890
-3,745
| -30% | -$439K | 0.11% | 147 |
|
|
2020
Q4 | $1.48M | Buy |
12,635
+897
| +8% | +$98.7K | 0.18% | 96 |
|
|
2020
Q3 | $1.21M | Sell |
11,738
-527
| -4% | -$52.9K | 0.17% | 104 |
|
|
2020
Q2 | $1.13M | Buy |
12,265
+975
| +9% | +$93.5K | 0.16% | 108 |
|
|
2020
Q1 | $1.02M | Buy |
11,290
+5,370
| +91% | +$571K | 0.27% | 81 |
|
|
2019
Q4 | $672K | Buy |
5,920
+661
| +13% | +$72.5K | 0.17% | 118 |
|
|
2019
Q3 | $571K | Buy |
5,259
+268
| +5% | +$28K | 0.16% | 128 |
|
|
2019
Q2 | $486K | Buy |
4,991
+1,449
| +41% | +$132K | 0.17% | 99 |
|
|
2019
Q1 | $322K | Sell |
3,542
-7,210
| -67% | -$645K | 0.11% | 139 |
|
|
2018
Q4 | $978K | Buy |
10,752
+428
| +4% | +$40K | 0.36% | 57 |
|
|
2018
Q3 | $950K | Sell |
10,324
-1,643
| -14% | -$152K | 0.37% | 55 |
|
|
2018
Q2 | $1.02M | Buy |
11,967
+1,585
| +15% | +$132K | 0.38% | 64 |
|
|
2018
Q1 | $833K | Buy |
10,382
+6,936
| +201% | +$572K | 0.29% | 86 |
|
|
2017
Q4 | $278K | Buy |
+3,446
| New | +$276K | 0.1% | 183 |
|
Other funds holding MDT
VCM
VPM
Csenge Advisory Group's MDT Position: Q1 2026 in Review
Csenge Advisory Group reduced its Medtronic (MDT) stake by 15% in Q1 2026, selling an estimated $339K and leaving 19,723 shares worth $1.71M. The position accounts for 0.08% of the portfolio, ranked #213.
Csenge Advisory Group first reported a position in MDT in Q4 2017 and has held it in 34 quarters since. The position peaked at $2.23M in Q4 2025. 2,230 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- Csenge Advisory Group held 19,723 shares of Medtronic worth $1.71M as of Q1 2026.
- Csenge Advisory Group sold 3,535 Medtronic shares in Q1 2026, an estimated $339K.
- Medtronic made up 0.08% of Csenge Advisory Group's portfolio in Q1 2026, its #213 holding.
- Csenge Advisory Group first reported a position in Medtronic in Q4 2017 and has held it in 34 quarters since.
- Csenge Advisory Group's Medtronic position peaked at $2.23M in Q4 2025.
- 2,230 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on Csenge Advisory Group's 13F filing for Q1 2026, filed 30 Apr 2026.